Ehlers-Danlos Syndrome (Classical Type)
Overview
Plain-Language Overview
Ehlers-Danlos Syndrome (Classical Type) is a genetic condition that affects the body's connective tissues, which provide strength and flexibility to the skin, joints, and blood vessels. People with this condition often have very stretchy skin that can be fragile and bruise easily. Their joints may be unusually flexible, leading to frequent dislocations or pain. The disorder primarily impacts the musculoskeletal system but can also affect the skin's appearance and healing. Because connective tissue is widespread, complications can involve multiple body systems. The condition is inherited and present from birth, affecting daily activities and sometimes causing chronic discomfort.
Clinical Definition
Ehlers-Danlos Syndrome (Classical Type) is a heritable connective tissue disorder characterized by defective collagen synthesis, primarily due to mutations in the COL5A1 or COL5A2 genes. This leads to abnormal type V collagen, resulting in skin hyperextensibility, joint hypermobility, and tissue fragility. The classical type is distinguished by its prominent cutaneous manifestations, including atrophic scarring and easy bruising, alongside musculoskeletal symptoms such as recurrent joint dislocations. The disorder follows an autosomal dominant inheritance pattern. Major clinical significance lies in the risk of chronic joint instability and skin complications, which can impair quality of life. Diagnosis is based on clinical features supported by molecular genetic testing.
Inciting Event
There is no specific external trigger; symptoms arise from inherited collagen defects present at birth.
Minor trauma or mechanical stress can precipitate joint dislocations or skin injury due to tissue fragility.
Latency Period
Symptoms such as skin hyperextensibility and joint hypermobility are often present from infancy or early childhood.
Diagnosis may be delayed despite early symptom onset due to variable expressivity and subtle initial signs.
Diagnostic Delay
Variable clinical presentation and overlap with other connective tissue disorders cause frequent misdiagnosis.
Lack of awareness and subtle early symptoms lead to delayed recognition of joint hypermobility syndrome.
Absence of a definitive laboratory test necessitates reliance on clinical criteria, which may be underutilized.
Clinical Presentation
Signs & Symptoms
Chronic joint pain and frequent joint dislocations or subluxations
Soft, velvety, and hyperextensible skin prone to bruising and poor healing
Atrophic, widened scars often described as 'cigarette paper' scars
Easy bruising and bleeding tendency without coagulation abnormalities
Muscle weakness and fatigue due to joint instability and connective tissue fragility
History of Present Illness
Patients report chronic joint pain and frequent joint dislocations or subluxations starting in childhood.
History of skin that stretches easily and wounds that heal with thin, atrophic scars is common.
Recurrent easy bruising and delayed wound healing are frequently described.
Some patients experience muscle weakness and fatigue related to joint instability.
Past Medical History
Previous episodes of joint dislocations or sprains without significant trauma are common.
History of poor wound healing or abnormal scarring after minor injuries or surgeries.
No specific medication or environmental exposures are typically associated with disease onset.
Family History
Autosomal dominant inheritance pattern with multiple affected family members across generations.
Relatives may have a history of joint hypermobility, skin hyperextensibility, or easy bruising.
Family history of spontaneous joint dislocations or poor wound healing supports diagnosis.
Physical Exam Findings
Skin hyperextensibility with smooth, velvety texture and abnormal wound healing
Joint hypermobility assessed by increased range of motion beyond normal limits
Atrophic scarring with thin, papyraceous scars often on the knees, elbows, and forehead
Molluscoid pseudotumors and subcutaneous spheroids over pressure points
Easy bruising with multiple ecchymoses in various stages of healing
Diagnostic Workup
Diagnostic Criteria
Diagnosis relies on the presence of major criteria including skin hyperextensibility and widened atrophic scars, combined with generalized joint hypermobility. Minor criteria include easy bruising, soft skin, and family history consistent with autosomal dominant inheritance. Confirmatory diagnosis is achieved through genetic testing identifying pathogenic variants in COL5A1 or COL5A2. Histopathology of skin biopsy showing abnormalities in collagen fibrils can support diagnosis but is less commonly used. Clinical evaluation using the Beighton score helps quantify joint hypermobility.
Pathophysiology
Key Mechanisms
Defective synthesis or processing of type V collagen due to mutations in the COL5A1 or COL5A2 genes leads to abnormal connective tissue structure.
Impaired collagen fibril formation results in weakened skin, joints, and blood vessel walls.
Increased tissue fragility causes skin hyperextensibility and joint hypermobility.
Abnormal collagen disrupts normal wound healing and increases risk of atrophic scarring.
Vascular fragility may contribute to easy bruising and bleeding complications.
| Involvement | Details |
|---|---|
| Organs | Skin shows hallmark features such as hyperextensibility, atrophic scarring, and easy bruising in classical Ehlers-Danlos syndrome. |
Blood vessels may be fragile, increasing the risk of bruising and vascular complications, although less severe than in vascular EDS. | |
| Tissues | Dermis is markedly affected, resulting in skin hyperextensibility and fragility due to defective collagen structure. |
Joint capsule and ligaments exhibit laxity and weakness, leading to joint hypermobility and frequent dislocations. | |
| Cells | Fibroblasts are responsible for producing defective type V collagen, leading to the characteristic connective tissue abnormalities in classical Ehlers-Danlos syndrome. |
| Chemical Mediators | Type V collagen is deficient or structurally abnormal due to mutations in COL5A1 or COL5A2, causing impaired collagen fibril formation and tissue fragility. |
Treatments
Pharmacological Treatments
Analgesics
- Mechanism:
Provide symptomatic relief of chronic musculoskeletal pain by modulating pain pathways.
- Side effects:
Gastrointestinal upset
Renal impairment
Sedation
- Clinical role:
Supportive
Vitamin C supplementation
- Mechanism:
Enhances collagen synthesis by acting as a cofactor for prolyl and lysyl hydroxylase enzymes.
- Side effects:
Gastrointestinal discomfort
Kidney stones in high doses
- Clinical role:
Adjunctive
Non-pharmacological Treatments
Physical therapy focusing on joint stabilization and strengthening to reduce joint hypermobility and prevent dislocations.
Avoidance of high-impact activities and trauma to minimize risk of skin and joint injury.
Use of protective braces or splints to support hypermobile joints and prevent injury.
Regular cardiovascular monitoring to detect and manage potential vascular complications early.
Prevention
Pharmacological Prevention
Pain management with NSAIDs to reduce inflammation and discomfort
Use of vitamin C supplementation may support collagen synthesis though evidence is limited
Avoidance of corticosteroids which can worsen skin fragility
No specific pharmacologic agents prevent connective tissue defects in classical EDS
Prophylactic antibiotics are not routinely indicated unless wounds are infected
Non-pharmacological Prevention
Physical therapy focusing on joint stabilization and muscle strengthening
Avoidance of high-impact activities to reduce risk of joint injury
Protective padding and braces to prevent joint dislocations
Regular cardiovascular monitoring for early detection of valvular abnormalities
Patient education on skin care and injury prevention to minimize trauma
Outcome & Complications
Complications
Joint dislocations and subluxations leading to chronic instability
Severe skin lacerations with delayed healing and widened scars
Arterial rupture is rare but possible in classical type due to vessel fragility
Early-onset osteoarthritis from repetitive joint injury
Chronic pain syndrome impairing quality of life
| Short-term Sequelae | Long-term Sequelae |
|---|---|
|
|
Differential Diagnoses
Ehlers-Danlos Syndrome (Classical Type) versus Marfan Syndrome
Ehlers-Danlos Syndrome (Classical Type) | Marfan Syndrome |
|---|---|
Autosomal dominant mutation in COL5A1 or COL5A2 genes | Autosomal dominant mutation in FBN1 gene |
Skin hyperextensibility and widened atrophic scars | Aortic root dilation and ectopia lentis |
Joint hypermobility with soft, velvety skin | Arachnodactyly, pectus excavatum, and tall stature |
Ehlers-Danlos Syndrome (Classical Type) versus Loeys-Dietz Syndrome
Ehlers-Danlos Syndrome (Classical Type) | Loeys-Dietz Syndrome |
|---|---|
Autosomal dominant mutation in COL5A1 or COL5A2 genes | Autosomal dominant mutation in TGFBR1 or TGFBR2 genes |
No significant arterial tortuosity or hypertelorism | Arterial tortuosity and widely spaced eyes (hypertelorism) |
Marked skin hyperextensibility with atrophic scars | Translucent skin with easy bruising but less skin hyperextensibility |
Ehlers-Danlos Syndrome (Classical Type) versus Osteogenesis Imperfecta
Ehlers-Danlos Syndrome (Classical Type) | Osteogenesis Imperfecta |
|---|---|
Autosomal dominant mutations in COL5A1 or COL5A2 genes | Mostly autosomal dominant mutations in COL1A1 or COL1A2 genes |
Joint hypermobility and skin hyperextensibility without fractures | Multiple fractures with minimal trauma and blue sclerae |
Normal bone density without fractures | Osteopenia and multiple healed fractures on X-ray |
Ehlers-Danlos Syndrome (Classical Type) versus Cutis Laxa
Ehlers-Danlos Syndrome (Classical Type) | Cutis Laxa |
|---|---|
Skin hyperextensibility with soft, velvety texture | Loose, sagging skin with decreased elasticity but not hyperextensible |
Autosomal dominant mutations in COL5A1 or COL5A2 genes | Can be autosomal dominant, recessive, or acquired |
Primarily skin and joint manifestations without emphysema | Pulmonary emphysema and hernias common |
Ehlers-Danlos Syndrome (Classical Type) versus Benign Joint Hypermobility Syndrome
Ehlers-Danlos Syndrome (Classical Type) | Benign Joint Hypermobility Syndrome |
|---|---|
Joint hypermobility with skin hyperextensibility and atrophic scars | Joint hypermobility without skin involvement or scarring |
Autosomal dominant mutation in COL5A1 or COL5A2 genes | Often familial but no known specific gene mutation |
Skin fragility and risk of vascular complications in some cases | Joint pain and dislocations without major vascular or skin complications |